KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $491,554 | +36.3% | 28,299 | +10.5% | 0.00% | – |
Q2 2023 | $360,729 | +31.2% | 25,620 | +0.2% | 0.00% | – |
Q1 2023 | $275,000 | +92492.6% | 25,561 | +28.9% | 0.00% | – |
Q4 2022 | $297 | -99.9% | 19,825 | +2.8% | 0.00% | – |
Q3 2022 | $248,000 | +41.7% | 19,288 | +6.1% | 0.00% | – |
Q2 2022 | $175,000 | -1.1% | 18,173 | +2.0% | 0.00% | – |
Q1 2022 | $177,000 | +4.7% | 17,825 | +23.8% | 0.00% | – |
Q4 2021 | $169,000 | +13.4% | 14,394 | +9.3% | 0.00% | – |
Q3 2021 | $149,000 | -16.3% | 13,167 | +3.2% | 0.00% | – |
Q2 2021 | $178,000 | -4.8% | 12,756 | +26.6% | 0.00% | – |
Q1 2021 | $187,000 | -11.0% | 10,073 | -15.2% | 0.00% | – |
Q4 2020 | $210,000 | +35.5% | 11,885 | +19.3% | 0.00% | – |
Q3 2020 | $155,000 | -4.9% | 9,965 | +55.3% | 0.00% | – |
Q2 2020 | $163,000 | +19.0% | 6,415 | -27.9% | 0.00% | – |
Q1 2020 | $137,000 | +168.6% | 8,895 | +94.2% | 0.00% | – |
Q4 2019 | $51,000 | +30.8% | 4,581 | +0.2% | 0.00% | – |
Q3 2019 | $39,000 | -25.0% | 4,574 | +19.4% | 0.00% | – |
Q2 2019 | $52,000 | 0.0% | 3,832 | +33.1% | 0.00% | – |
Q1 2019 | $52,000 | +10.6% | 2,880 | +73.7% | 0.00% | – |
Q4 2018 | $47,000 | +23.7% | 1,658 | +10.3% | 0.00% | – |
Q3 2018 | $38,000 | – | 1,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |